Steve Coen's Restricted Stock Vesting and Sale
2025-10-21SEC Filing 144 (0001959173-25-006512)
Steve Coen, an officer of Ginkgo Bioworks Holdings, Inc., has reported the vesting and sale of Class A restricted stock. On October 16, 2025, Coen acquired 1,312 shares of Class A stock through restricted stock vesting as part of his compensation. Subsequently, on October 21, 2025, Coen sold these shares, with the sale including an amount necessary to cover a tax obligation resulting from the settlement of the vested equity award distribution. The aggregate market value of the sold shares was $17,907.89. Additionally, Coen had previously sold 310 shares of Class A stock on August 22, 2025, for gross proceeds of $3,842.79. The transactions were facilitated by Fidelity Brokerage Services LLC.
Tickers mentioned in this filing:DNA
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1830214/0001959173-25-006512.txt